Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1.
Fleming
F J
FJ
Department of Surgery, Saint Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
Myers
E
E
Kelly
G
G
Crotty
T B
TB
McDermott
E W
EW
O'Higgins
N J
NJ
Hill
A D K
AD
Young
L S
LS
D000328:Adult; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D016022:Case-Control Studies; D019008:Drug Resistance, Neoplasm; D005260:Female; D051548:Histone Acetyltransferases; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D056920:Nuclear Receptor Coactivator 1; D056921:Nuclear Receptor Coactivator 3; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D014157:Transcription Factors / Q000032:analysis*
D014408:Biomarkers, Tumor; D051548:Histone Acetyltransferases; D056920:Nuclear Receptor Coactivator 1; D056921:Nuclear Receptor Coactivator 3; D018719:Erb-b2 Receptor Tyrosine Kinases; D014157:Transcription Factors; C065788:transcription factor PEA3; C538859:NCOA1 protein, human